Board of Directors

To view committee charters and membership, please click here.

John C. Lechleiter, Ph.D.

John C. Lechleiter, Ph.D.

Chairman

Eli Lilly and Company

David A. Ricks

David A. Ricks

President and Chief Executive Officer

Eli Lilly and Company

Ralph Alvarez

Ralph Alvarez

Executive Chairman

Skylark Co., Ltd.

Katherine Baicker, Ph.D.

Katherine Baicker, Ph.D.

Professor of Health Economics, Harvard T.H. Chan School of Public Health

Harvard University

Carolyn R. Bertozzi, Ph.D.

Carolyn R. Bertozzi, Ph.D.

Anne T. and Robert M. Bass Professor of Chemistry and Professor of Chemical & Systems Biology and Radiology

Stanford University

Michael L. Eskew

Michael L. Eskew

Former Chairman and Chief Executive Officer

United Parcel Service, Inc.

J. Erik Fyrwald

J. Erik Fyrwald

President and Chief Executive Officer

Univar Inc.

R. David Hoover

R. David Hoover

Former CEO and Chairman of the Board

Ball Corporation

Jamere Jackson

Jamere Jackson

Chief Financial Officer

Nielsen Holdings plc

William G. Kaelin, Jr., M.D.

William G. Kaelin, Jr., M.D.

Professor, Department of Medicine, and Associate Director, Basic Science

Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Dana-Farber/Harvard Cancer Center

Juan R. Luciano

Juan R. Luciano

Chairman and Chief Executive Officer

Archer Daniels Midland Company

Ellen R. Marram

Ellen R. Marram

President

The Barnegat Group LLC

Franklyn G. Prendergast, M.D., Ph.D.

Franklyn G. Prendergast, M.D., Ph.D.

Emeritus Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Emeritus Professor of Molecular Pharmacology and Experimental Therapeutics

Mayo Medical School

Marschall S. Runge, M.D., Ph.D.

Marschall S. Runge, M.D., Ph.D.

Executive Vice President for Medical Affairs

University of Michigan

Kathi P. Seifert

Kathi P. Seifert

Retired Executive Vice President

Kimberly-Clark Corporation

Jackson Tai

Jackson Tai

Former Vice Chairman and Chief Executive Officer

DBS Group Holdings Ltd. and DBS Bank Ltd.

Dave Ricks is president and chief executive officer of Eli Lilly and Company, and he has been elected chairman of the company’s board, effective June 1, 2017.

A 20-year Lilly veteran, Ricks served as president of Lilly Bio-Medicines from 2012 to 2016. Previously, he was president of Lilly USA, the company’s largest affiliate, from 2009 to 2012. He served as president and general manager of Lilly China, operating in one of the world’s fastest-growing emerging markets, from 2008 to 2009. And he was general manager of Lilly Canada from 2005 to 2008, after roles as director of pharmaceutical marketing and national sales director in that country. Ricks joined Lilly in 1996 as a business development associate and held several management roles in U.S. marketing and sales before moving to Lilly Canada.

Ricks earned a Bachelor of Science from Purdue University in 1990 and an MBA from Indiana University in 1996.

Ricks serves on the board of the Pharmaceutical Research and Manufacturers of America (PhRMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), and the Central Indiana Corporate Partnership. He chairs the Riley Children’s Foundation Board of Governors.